How does myTomorrows support expanded access programs?

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

1 mins read

share this post

We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas:

free-of-charge or paid-for
single patient or cohort programs
post-trial access

Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance.

share this post

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

more articles

view all blogs

Whitepaper: Advancing Neuro-Oncology Clinical Trial Access

Daniël Groeneweg

27 Nov 2025

8 mins read

Person with end-stage Parkinson's and caregiver

End-Stage Parkinson’s Disease: Symptoms, Care, and Support

Andrea Enguita

18 Nov 2025

21 mins read

Getting Started: myTomorrows Referral Platform for Site Staff

Adrianne Rivard

14 Nov 2025

10 mins read

myTomorrows Avego finding announcement

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read

ALS patient flow

Accelerating ALS Clinical Trial Recruitment in the U.S.

Dennis Akkaya

10 Oct 2025

12 mins read

Vanessa Lemarie

myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten

10 Oct 2025

2 mins read

Smarter Clinical Trial Recruitment that Delivers Faster Site Enrollment

Dennis Akkaya

18 Sep 2025

10 mins read

Woman with Multiple System Atrophy using a cane to walk

Exploring the Symptoms of Multiple System Atrophy

Andrea Enguita

13 Aug 2025

15 mins read

James Griffin sickle cell patient advocate

Treatment Advances and Patient Advocacy in Sickle Cell Disease: A Conversation with James Griffin

John Massarelli

7 Aug 2025

10 mins read

Searching for Solutions: How Physicians Navigate Trial Access and Technology

Michel van Harten

17 Jul 2025

4 mins read